These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408 [No Abstract] [Full Text] [Related]
8. [Circadian rhythm of cortisol secretion in diabetes mellitus patients]. Vakov L Vutr Boles; 1984; 23(3):77-85. PubMed ID: 6464437 [TBL] [Abstract][Full Text] [Related]
9. Glucagon secretion in subjects with prediabetes, diabetes mellitus and obesity. Slavnov VN; Epshtein EV; Efimov AS; Malinkovich VD; Stepanenko LI Endocrinologie; 1979; 17(3):213-8. PubMed ID: 504963 [TBL] [Abstract][Full Text] [Related]
10. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Tsai AC; Vinik AI; Lasichak A; Lo GS Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482 [TBL] [Abstract][Full Text] [Related]
11. [Local mechanisms of relationship between colloid-osmotic pressure and ophthalmic tone in patients with diabetes mellitus]. Zapuskalov IV; Krivosheina OI; Tsyrov GI Vestn Oftalmol; 1998; 114(2):43-4. PubMed ID: 9621822 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus. Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198 [TBL] [Abstract][Full Text] [Related]
13. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. Gerich JE; Lorenzi M; Karam JH; Schneider V; Forsham PH JAMA; 1975 Oct; 234(2):159-5. PubMed ID: 1242153 [TBL] [Abstract][Full Text] [Related]
14. Re: A comparison of classification schemes for ketosis-prone diabetes. Nalini R; Maldonado M; Balasubramanyam A Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157 [No Abstract] [Full Text] [Related]
15. The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes. Aydin I; Raskin P; Unger RH Diabetologia; 1977 Dec; 13(6):629-36. PubMed ID: 590654 [No Abstract] [Full Text] [Related]
16. [Sensitivity to insulin in patients with diabetes mellitus]. Levchenko TP Probl Endokrinol (Mosk); 1984; 30(5):13-6. PubMed ID: 6095255 [TBL] [Abstract][Full Text] [Related]
17. Toward risk factor control for all patients with diabetes. Whitehouse F Diabetes Care; 1992 Nov; 15(11):1818-20. PubMed ID: 1468321 [No Abstract] [Full Text] [Related]
18. Hypophyseo-adrenocortical function in diabetes mellitus. Asfeldt VH Acta Med Scand; 1972 Apr; 191(4):349-54. PubMed ID: 5032680 [No Abstract] [Full Text] [Related]
19. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus. Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427 [TBL] [Abstract][Full Text] [Related]
20. [Secretion of pancreatic polypeptide and glucagon in patients with diabetes mellitus after the administration of insulin]. Kuska J; Kokot F; Błasiak M Endokrynol Pol; 1985; 36(6):323-31. PubMed ID: 3914417 [No Abstract] [Full Text] [Related] [Next] [New Search]